AU2003206945A8 - Use of proteinase inhibitors in the treatment of autoimmune diseases - Google Patents

Use of proteinase inhibitors in the treatment of autoimmune diseases

Info

Publication number
AU2003206945A8
AU2003206945A8 AU2003206945A AU2003206945A AU2003206945A8 AU 2003206945 A8 AU2003206945 A8 AU 2003206945A8 AU 2003206945 A AU2003206945 A AU 2003206945A AU 2003206945 A AU2003206945 A AU 2003206945A AU 2003206945 A8 AU2003206945 A8 AU 2003206945A8
Authority
AU
Australia
Prior art keywords
treatment
autoimmune diseases
proteinase inhibitors
proteinase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003206945A
Other versions
AU2003206945A1 (en
Inventor
Peter Sondermann
Robert Huber
Uwe Jacob
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10241411A external-priority patent/DE10241411A1/en
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of AU2003206945A8 publication Critical patent/AU2003206945A8/en
Publication of AU2003206945A1 publication Critical patent/AU2003206945A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003206945A 2002-02-22 2003-02-21 Use of proteinase inhibitors in the treatment of autoimmune diseases Abandoned AU2003206945A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10207744 2002-02-22
DE10207744.4 2002-02-22
DE10241411A DE10241411A1 (en) 2002-02-22 2002-09-06 Use of proteinase inhibitors for the treatment of autoimmune diseases
DE10241411.4 2002-09-06
PCT/EP2003/001807 WO2003070229A2 (en) 2002-02-22 2003-02-21 Use of proteinase inhibitors in the treatment of autoimmune diseases

Publications (2)

Publication Number Publication Date
AU2003206945A8 true AU2003206945A8 (en) 2003-09-09
AU2003206945A1 AU2003206945A1 (en) 2003-09-09

Family

ID=27758411

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003206945A Abandoned AU2003206945A1 (en) 2002-02-22 2003-02-21 Use of proteinase inhibitors in the treatment of autoimmune diseases

Country Status (2)

Country Link
AU (1) AU2003206945A1 (en)
WO (1) WO2003070229A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1485345T3 (en) 2002-03-11 2008-11-03 Curacyte Ag Urokinase Inhibitors, Their Preparation and Use
DE10301300B4 (en) 2003-01-15 2009-07-16 Curacyte Chemistry Gmbh Use of acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein
DE10322191B4 (en) * 2003-05-16 2014-02-27 The Medicines Company (Leipzig) Gmbh N-sulfonylated amino acid derivatives, process for their preparation and their use
DE10342108A1 (en) 2003-09-11 2005-04-14 Curacyte Chemistry Gmbh Basic substituted benzylamine analogs as coagulation factor Xa inhibitors, their preparation and use
WO2007025718A1 (en) * 2005-08-29 2007-03-08 Wilex Ag Oxadiazole compounds as urokinase inhibitors
DE102006050672A1 (en) 2006-10-24 2008-04-30 Curacyte Discovery Gmbh New glycylglycine derivatives with a benzylsulfonylamido group and an amidino-organylamido group at the opposite chain ends, used in drugs for reducing loss of blood, e.g. in operations
US20120172375A1 (en) * 2008-11-07 2012-07-05 Bruce Trapp Compounds and methods of promoting oligodendrocyte precursor differentiation
US8921319B2 (en) 2010-07-07 2014-12-30 The Medicines Company (Leipzig) Gmbh Serine protease inhibitors
DE102011108346A1 (en) * 2011-07-25 2013-01-31 Philipps-Universität Marburg Use of inhibitors of TMPRSS2 as a drug
WO2016144654A1 (en) 2015-03-09 2016-09-15 Washington University Inhibitors of growth factor activation enzymes
JP2020527582A (en) * 2017-07-21 2020-09-10 レッド ヒル バイオファーマ リミテッドＲｅｄＨｉｌｌ Ｂｉｏｐｈａｒｍａ Ｌｔｄ． Use of WX-UK1 and its prodrug, WX-671, for the treatment of non-cancerous medical conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843905A (en) * 1993-06-04 1998-12-01 Vertex Pharmaceuticals, Incorporated Peptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitors
CZ237697A3 (en) * 1995-02-10 1998-04-15 Basf Aktiengesellschaft Derivative of peptidic p-amidinobenzylamide as thrombin inhibitor and intermediates for preparing thereof
US5834487A (en) * 1996-09-24 1998-11-10 Cv Therapeutics Inhibition of 26S and 20S proteasome by indanones
WO2000061608A2 (en) * 1999-04-09 2000-10-19 Basf Aktiengesellschaft Low-molecular inhibitors of complement proteases
US6358928B1 (en) * 1999-11-22 2002-03-19 Enzyme Systems Products Peptidyl sulfonyl imidazolides as selective inhibitors of serine proteases
FR2819254B1 (en) * 2001-01-08 2003-04-18 Fournier Lab Sa NOVEL N- (PHENYLSULFONYL) GLYCINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR OBTAINING PHARMACEUTICAL COMPOSITIONS
US6841571B2 (en) * 2001-10-29 2005-01-11 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cysteine proteases

Also Published As

Publication number Publication date
WO2003070229A3 (en) 2004-03-04
AU2003206945A1 (en) 2003-09-09
WO2003070229A2 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
IL166780A0 (en) Use of ikappab-kinase inhibitors in pain therapy
IL164211A0 (en) Il-18 inhibitors and peripheral vascular diseases
HRP20041029A2 (en) Therapeutic use of selcetive pde10 inhibitors
HK1068885A1 (en) N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases n--
AU2003303128A8 (en) Inhibitors and methods of use thereof
HK1079789A1 (en) Vasculostatic agents and methods of use thereof
PL374598A1 (en) Caspase inhibitors and uses thereof
ZA200410409B (en) Use of thio-oxindole derivatives in treatment of hormonerelated conditions
AU2003249645A8 (en) Methods for the identification of ikkalpha function and other genes useful for treatment of inflammatory diseases
AU2003293099A8 (en) Treatment of dna damage related disorders
AU2003206945A8 (en) Use of proteinase inhibitors in the treatment of autoimmune diseases
GB0207411D0 (en) Azole compounds and their therapeutic use
GB0207410D0 (en) Compounds and their therapeutic use
GB0219660D0 (en) Therapeutic use
SG110107A1 (en) Compound and use in treatment
IL166062A0 (en) Compositions and methods for therapeutic treatment
GB2392839A8 (en) Use of Mycobacterium w in the treatment of tubercolosis
AU2003240446A1 (en) Use of mob-5 in pain
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
GB0221712D0 (en) Methods of treatment
AU2003302271A8 (en) Methods of treating and/or preventing autoimmune diseases
AU2003244437A1 (en) Quinoxalinones and their use especially in the treatment of cardiovascular diseases
IL165935A0 (en) Use of vasopeptidase inhibitors in the treatment of nephropathy
GB0305699D0 (en) Therapeutic compositions and methods
GB0215773D0 (en) Compunds and their therapeutic use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase